RNA Anticoagulant Contract Manufacture and Testing for Late Preclinical and Early Clinical Studies
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Helixomer, Inc.
Award Date
Award Amount
100,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Thomas LaBean
Fiscal Year
2021
Region
Research Triangle
Project Description:
Helixomer, Inc. is developing a novel injectable RNA origami-base anticoagulant (direct thrombin inhibitor) and reversal agent. The company was awarded a $100,000 SRL to help fund CMO production of the anticoagulant and reversal agent for use in non-rodent pre-clinical studies and bioanalytical assay development.